Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Medical Health Institute

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Medical Health Institute head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 488 · Grade C

Medical Health Institute

Visit Medical Health Institute Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 51 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Medical Health Institute a bad call — it's best for people considering a medically supervised weight-care program who obtain the actual medication and payment agreement before committing. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
70
Transparency
90
47
Access Breadth
93
30
Clinical Oversight
92
66
Track Record
88
54
CoreAge RxBrief Score 94 · 51Medical Health Institute

Price, coverage & the tracker

CoreAge RxMedical Health Institute
Brief Score94/100 (A)51/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current medication quote unconfirmed

GLP-1 care described without a current named preparation or complete medication-specific price. Consultation, labs and monitoring need an itemized quote.

Self-pay service; recurring cadence disclosed in the program agreement. Dispensed prescriptions generally nonrefundable; other service refunds require the actual terms.

Full price details

Current semaglutide preparation and complete quote unknown; public weight-loss page describes GLP-1 care without establishing a named molecule-specific offer

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current medication quote unconfirmed

GLP-1 care described without a current named preparation or complete medication-specific price. Consultation, labs and monitoring need an itemized quote.

Self-pay service; recurring cadence disclosed in the program agreement. Dispensed prescriptions generally nonrefundable; other service refunds require the actual terms.

Full price details

Current tirzepatide preparation and complete quote unknown; public weight-loss page describes GLP-1 care without establishing a named molecule-specific offer

CoverageUS only; restrictions by state, confirmed at intakeService requires eligible residence and provider licensure under the terms; a complete current medication-specific state list was not established
Brand-name accessNot confirmedThe reviewed pages do not establish a current named branded GLP-1 prescribing program; confirm the exact prescription.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Medical Health Institute: GLP-1 care described without a named current preparation or full drug quote. Self-pay program fees may recur; dispensed prescriptions generally nonrefundable under the terms.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.